US 12350313
Activin receptor type IIa variants and methods of use thereof
granted A61KA61K38/00A61K38/18
Quick answer
US patent 12350313 (Activin receptor type IIa variants and methods of use thereof) held by Keros Therapeutics, Inc. expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Keros Therapeutics, Inc.
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/18, A61K47/64, A61K47/65